What is Byduron? What are their Side Effects?

What is Bydureon (exenatide)?

Bydureon is a brand-name medicine used to improve blood sugar levels in people with type 2 diabetes. It comes as a liquid suspension to be given by injection under the skin (subcutaneously).

Bydureon contains a medicine called extended-release exenatide.

Bydureon vs Bydureon BCise

Bydureon BCise is another form of Bydureon. It contains the same medicine (extended-release exenatide). Bydureon and Bydureon BCise work in the same way and have very similar effects in the body. You push the autoinjector against your skin, and it injects the medicine automatically.

There are fewer steps required to inject Bydureon using this autoinjector than using a syringe or pen injector. This can make Bydureon BCise easier to use than Bydureon.

In clinical studies, Bydureon reduced hemoglobin A1c (HbA1c) by approximately 0.88 to 1.6 percent after 24 to 28 weeks of treatment. In the Bydureon BCise study, HbA1c was reduced by approximately 1.07 to 1.39 percent after 28 weeks of treatment.

Bydureon (exenatide) Generic

Bydureon is available only as a brand-name drug. It is not available in a generic form. Bydureon contains extended-release exenatide.

Bydureon (exenatide) side effects

Bydureon can cause mild or severe side effects. The following list is some of the major side-effects which may occur when taking Byduron.

For more information about the possible side effects of Bydureon, or for tips on how to deal with bothersome side effects, talk to your doctor or pharmacist.

More Common Side Effects

The more common side effects of Bydureon may include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Headache
  • fatigue
  • Upset stomach
  • decreased appetite

• Injection site reactions such as redness, itching, or a lump under the skin

Some of these side effects may go away in a few days or even a few weeks.

Location: New Delhi, Delhi, India

Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·          fast weight gain (greater than 10 pounds within a week) ·          bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m
Read more

The BEST HIV MEDICINE DISTRIBUTOR IN DELHI

Image
  If you're in search of an HIV medication distributor in Delhi, you've come to the right place. There are many options to choose from - NCPI+,Alleviareindia. GSNP+ and a few other brands. Here are some factors to consider. NCPI+ The NCPI+ HIV MEDICINE DISRIBUTOR IN DELHI works to provide HIV medications to people in need in the country. The medicines are incredibly expensive in the open market. However, the government is providing free antiretroviral drugs to 2.1 million people in India. The government procures these drugs through a tender process. The medicines are not readily available at the patient's home, so they need to be transported to the person who needs it most. There are several reasons for this. First, people need to be protected from police. While traveling, they need to present a pass issued by the government or a state AIDS control society. In some cases, police have torn people's green books, forcing them to go without access to the medicines. This has
Read more